TSE:MFC

Manulife Financial (MFC.TO)

60.67
+0.26 (0.43%)
as of Jul 22, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 22, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mostly positive outlook among various experts, highlighting its competitive positioning within the Canadian financial sector, particularly in comparison to major banks like TD and SLF. Analysts note MFC's ongoing strength in wealth management and healthy growth prospects in Asia, although there are concerns regarding its current valuation, as it trades over 2x book value and exhibits only moderate earnings growth. Despite being classified as slightly overbought, its charts remain healthy, with many recommending caution yet seeing potential for growth in the long run. The company's strong dividend yield and management strategies, particularly in alternative investments, also contribute to a favorable long-term investment story, although short-term volatility may present opportunities for those willing to enter at lower price points.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF,SLF
TOP PICK

Their big product was guaranteeing a life insurance policy on stock returns. So, when the market melted down, there was a big scare. Now, the market has come back, and those policies won't lose as much. MFC used to be held up by a fortress balance sheet. 15 years later, they've grown into that balance sheet. Saw nice earnings growth in 2023 and expects it also for 2024.

(Analysts’ price target is $35.37)
PAST TOP PICK
(A Top Pick Dec 12/22, Up 44%)

Business headed in right direction. Profitability increasing, return on equity also strong. New management has turned things around. Current yield ~5% is very stable. Interest rates not a concern - have weather rising rates well. Would continue to buy - still owns shares. 

BUY

MFC is the name in the Insurance space that keeps working. A few years ago, it was like that cough syrup -- doesn't taste good, but it works. Insurance companies are set to outperform banks. MFC is #1, SLF #2, POW #3.

TOP PICK

Share price up nicely - a little strong, but overall very good trends.. Excellent balance sheet strength. Capital allocation very strong the past few years. Excellent CEO. Recently selling problematic assets. Seeing rebound in Asia market. Good for shareholders in the long term. Core holding in income portfolio. 

HOLD

Ranks a bit higher than SLF on his screens, but it's not by a significant amount. Exposure to Asia, a growing market. Yield is 4.9%, dividend should increase over time.

Some of the insurers are outperforming the banks because they're a bit more levered to falling interest rates, fewer credit concerns and loan-loss provisions. Likes banks, too.

DON'T BUY

At best - under performer. Not the best option for investors. More Asia exposure than North America. Would prefer Sun Life. Not a good investment for long term. Don't buy. 

BUY

Banks are a tougher story due to capital ratios and inability to grow. Instead of a bank, look to MFC or SLF.

BUY

Stock performance a good sign for momentum investors. Resistance in share price appears to have ebbed. Would recommenced buying based on seasonal basis. 

PAST TOP PICK
(A Top Pick Nov 28/23, Up 9%)

Excellent franchise with highest credit ratings in the world. Very good debt levels. New CEO performing very well. Last year saw dividend increase. Higher interest rates mean better returns for the business. Will continue to own shares. 

TOP PICK

Breaking out of a more than decade-long range. Finally have some fundamentals on LTC portfolio. Reinsurance deal was better than expected. Underlying business performing pretty well. Asia has both potential and potential risks. Not expensive. Have to see if the big institutional money moves in. Yield is 5.05%.

(Analysts’ price target is $31.11)
BUY

It's popped slightly recently. They just did a deal in which they released $1.2 billion of free capital--this finally woke up people that MFC is a little undervalued. It still is at 8x PE with a price-to-book of 1.3x. Under this CEO in recent years, they've been streamlining operations to be more efficient and adding growth. This has been a top pick of his many times.

WATCH

Widely held. Had been stuck in a trading range for years. However, finally breaking out. Last week's transaction has prompted a look with fresh eyes. De-risked US business, prompting stock re-rating. Warming up to it, might pull the trigger in the new year.

BUY

Interest rate sensitive business. Would recommend buying based on chart. Sees new highs going forward. Owns shares in portfolio. Chart looking great. 

BUY

Doing well with their Asian (Hong Kong) operations. Results have been positive recently while improving bond yields helps them. Short-term prospects are good.

TOP PICK

Is buying back stock, an ROE of 17%, and pays a 5.5% dividend. Likes their geographic footprint.

(Analysts’ price target is $22.22)
Showing 91 to 105 of 2,283 entries